The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma

Journal of Drugs in Dermatology

Volumn 9, Issue 2, 2010, Pages 122-126

  Farhadi, Mohammad ^a   Kamrava, Seyed Kamran ^a   Behzadi, Ashkan Heshmatzade ^a   Rafiezadeh, Parviz ^a   Asghari, Alimohamad ^a   Rezvan, Farhad ^a   Maleki, Shayan ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; MALE; PAIN; PATIENT REFERRAL; PHOTODYNAMIC THERAPY; RECURRENT CANCER; SKIN BURNING SENSATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; AGED; MIDDLE AGED; PHOTOCHEMOTHERAPY; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 77949896153     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med. 1993;328(3):184-194.
2. Alpsoy E, Yikmaz E, Basaran E, Yazar S. Comparison of the effects of intralesional interferon alfa-1a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma. J Dermatol. 1996;23:394-396. (Pubitemid 26234863)
3. Netscher DT, Spira M. Basal cell carcinoma: An overview of tumor biology and treatment. Plast Reconstr Surg. 2004;113:74-94.
4. Staples M, Elwood M, Burton RC, et al. Nonmelanoma skin cancer in Australia: The 2002 national survey and trends since 1985. Med J Aust. 2006;184:6-10. (Pubitemid 43149790)
5. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol. 1994;30:774-778. (Pubitemid 24157120)
6. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147:41-47. (Pubitemid 34779436)
7. Head CS, Luu Q, Sercarz J, Saxton R. Photodynamic therapy and tumor imaging of hypericin-treated squamous cell carcinoma. J Surg Oncol. 2006,4:87.
8. Saabye Bøgelund F, Ashlede Philipsen P, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol. 2007;87:330-334.
9. Langius A, Bjorvell H, Lind MG. Functional status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck. 1994;16(6):559-568. (Pubitemid 24326619)
10. Dougherty TJ. Photodynamic therapy. 10. Photochem Photobiol. 1993;58(6):895-900.
11. Henderson BW, Dougherty T.J. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-157.
12. Raab GH, Schneilder AF, Eirmann W, et al. Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy. Arch Gynecol Obstet. 1990;248:13-20. (Pubitemid 20325756)
13. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. Inter Soc Photo Ther in Dermatol. 2005. J Am Acad Dermatol. 2007;56:125-143. (Pubitemid 44969292)
14. Christensen E, Skogvoll E, Viset T, et al. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: A 6-year clinical and histological follow-up. JEADV. 2009;23:58-66.
15. Kuijpers DI, Thissen MR, Neumann MH. Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol. 2002;3:247-259. (Pubitemid 34615388)
16. Swanson NA. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol. 1983;119:761-773.
17. Ramachandran S, Fryer AA, Lovatt TJ, et al. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: Use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Lett. 2003;189:175-181. (Pubitemid 35469126)
18. Korbelik M. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med. 2006;38:500-508.
19. Rhodes LE, De Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy versus surgery for nodular basal cell carcinoma. Arch Dermatol. 2007;143:1131-1136. (Pubitemid 47443364)
20. Rippey JJ. Why classify basal cell carcinomas? Histopathology. 1998;32:393-398. (Pubitemid 28231370)
21. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:567-574. (Pubitemid 32232013)
22. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin (Review). Cochrane Database of Systematic Reviews. 2009;Issue 2.
23. Wang I, Bendsoe N, Klinteberg CAF, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: Results of a phase III clinical trial. Br J Dermatol. 2000;144:832-840.
24. Allman R, Cowburn P, Mason M. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. Br J Cancer. 2000;83:655-661. (Pubitemid 30636309)
25. D'Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study of 128 patients. Head Neck Surg. 2004;26(3):232-240. (Pubitemid 38292733)